Three of the four mutations observed in the two cancer types occur in proximity to a site that binds beta-catenin (Figure 5d), a well-studied protein involved in the Wnt signaling pathway, and implicated in several malignancies, such as colon cancer, melanoma, medulloblastoma and others (66). Here, CTNNB1 is linked to cancer.